This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Amyris Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Amyris han disminuido a una tasa media anual de -593.5%, mientras que en la industria Chemicals los beneficios crecieron en un 11.1% anualmente. Los ingresos han ido creciendo a una tasa media de 20.5% al año.

Información clave

-593.5%

Tasa de crecimiento de los beneficios

-530.6%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals	12.9%
Tasa de crecimiento de los ingresos	20.5%
Rentabilidad financiera	n/a
Margen neto	-229.1%
Última actualización de beneficios	31 Mar 2023

Actualizaciones de resultados anteriores recientes

Recent updates

What Does Amyris, Inc.'s (NASDAQ:AMRS) Share Price Indicate?

Apr 12

Does This Valuation Of Amyris, Inc. (NASDAQ:AMRS) Imply Investors Are Overpaying?

Mar 22

At US$2.95, Is Amyris, Inc. (NASDAQ:AMRS) Worth Looking At Closely?

Oct 31

Amyris Cost Breakdown

Oct 07

Recurring Marketing Exclusivity Deals Accelerate Amyris On Path To Profitability

Oct 01

Are Investors Undervaluing Amyris, Inc. (NASDAQ:AMRS) By 43%?

Sep 02

Amyris: In Dire Need For Additional Capital

Aug 22

Amyris, Inc. (NASDAQ:AMRS) Just Reported, And Analysts Assigned A US$10.91 Price Target

Aug 12

Amyris' Vertically-Integrated Business Model Transitioning From Investment Mode To Payoff Mode

Aug 08

Desglose de ingresos y gastos

Cómo gana y gasta dinero Amyris. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

OTCPK:AMRS.Q Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Mar 23	268	-615	484	0
31 Dec 22	270	-529	495	0
30 Sep 22	259	-341	455	0
30 Jun 22	236	-213	400	0
31 Mar 22	223	-89	328	0
31 Dec 21	342	-270	259	0
30 Sep 21	357	-417	200	0
30 Jun 21	343	-467	168	0
31 Mar 21	321	-585	144	0
31 Dec 20	173	-382	137	0
30 Sep 20	134	-351	143	0
30 Jun 20	135	-325	138	0
31 Mar 20	167	-293	137	0
31 Dec 19	153	-270	134	0
30 Sep 19	128	-240	119	0
30 Jun 19	108	-258	112	0
31 Mar 19	60	-202	101	0
31 Dec 18	64	-223	91	0
30 Sep 18	112	-287	84	0
30 Jun 18	122	-253	73	0
31 Mar 18	133	-250	69	0
31 Dec 17	128	-202	64	0
30 Sep 17	85	-139	57	0
30 Jun 17	87	-116	53	0
31 Mar 17	71	-119	48	0
31 Dec 16	67	-97	48	0
30 Sep 16	55	-94	48	0
30 Jun 16	37	-151	51	0
31 Mar 16	35	-185	54	0
31 Dec 15	34	-222	56	0
30 Sep 15	36	-118	57	4
30 Jun 15	44	-78	57	4
31 Mar 15	45	-66	56	4
31 Dec 14	43	2	55	0
30 Sep 14	47	-195	56	0
30 Jun 14	38	-183	55	0
31 Mar 14	39	-186	56	0
31 Dec 13	41	-235	57	4
30 Sep 13	32	-139	60	0
30 Jun 13	44	-135	64	0

Ingresos de calidad: AMRS.Q actualmente no es rentable.

Margen de beneficios creciente: AMRS.Q actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: No hay datos suficientes para determinar si la tasa de crecimiento año a año de los beneficios de AMRS.Q ha sido positiva en los últimos 5 años.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de AMRS.Q en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: AMRS.Q no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Chemicals (-3.7%).

Rentabilidad financiera

Alta ROE: El pasivo de AMRS.Q supera su activo, por lo que es difícil calcular su rentabilidad financiera.

This company listing is no longer active

Amyris Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2023 earnings: EPS misses analyst expectations

Full year 2022 earnings: EPS and revenues miss analyst expectations

Amyris, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Amyris, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Amyris, Inc. to Report Q1, 2022 Results on May 10, 2022

Recent updates

Kathy L. Fortmann to Join Amyris, Inc. as Member of the Board of Directors

Amyris, Inc. announced delayed annual 10-K filing

Third Amended Joint Reorganization Plan Filed by Amyris, Inc.

Foris Ventures Provides Information to the Shareholders

Amyris, Inc. Announces Resignation of Elizabeth Dreyer as Chief Accounting Officer and Corporate Controller, Effective as of January 2, 2024

Amyris, Inc. announced delayed 10-Q filing

Nasdaq to Delist the Common Stock of Amyris

Amyris, Inc. Appoints Scott White as A Class II Director

Motion for Joint Administration Filed by Amyris, Inc.

Amyris' Common Stock To Be Delisted from Nasdaq

Amyris, Inc. announced delayed 10-Q filing

Amyris, Inc. Filed for Bankruptcy

Amyris, Inc. Announces Executive Changes

Amyris Receives Deficiency Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement

First quarter 2023 earnings: EPS misses analyst expectations

Consensus EPS estimates upgraded to US$0.75 loss

Price target increased by 9.0% to US$3.40

What Does Amyris, Inc.'s (NASDAQ:AMRS) Share Price Indicate?

Does This Valuation Of Amyris, Inc. (NASDAQ:AMRS) Imply Investors Are Overpaying?

Full year 2022 earnings: EPS and revenues miss analyst expectations

No longer forecast to breakeven

Price target decreased by 8.2% to US$3.12

Amyris Launches 4U by Tia™ Haircare Line Exclusively At Walmart

Amyris, Inc. announced that it expects to receive $20.000001 million in funding from Foris Ventures, LLC

Amyris, Inc. Announces Executive Changes

No longer forecast to breakeven

No longer forecast to breakeven

Forecast to breakeven in 2024

Amyris, Inc. Provides Financial Guidance for the Fourth Quarter of 2022

Price target decreased to US$9.31

Amyris, Inc. to Report Q3, 2022 Results on Nov 08, 2022

At US$2.95, Is Amyris, Inc. (NASDAQ:AMRS) Worth Looking At Closely?

Amyris, Inc. Launches Two New Consumer Brands

Amyris, Inc. Announces Three of Its Consumer Brands Will Be Included in Sephora's Launch in the United Kingdom

Amyris Cost Breakdown

Recurring Marketing Exclusivity Deals Accelerate Amyris On Path To Profitability

Elizabeth Dreyer Joins Amyris, Inc. as Chief Accounting Officer & Corporate Controller, Effective October 11, 2022

CFO & Chief Administration Officer recently sold US$74k worth of stock

Are Investors Undervaluing Amyris, Inc. (NASDAQ:AMRS) By 43%?

Amyris: In Dire Need For Additional Capital

President recently bought US$69k worth of stock

Amyris, Inc. (NASDAQ:AMRS) Just Reported, And Analysts Assigned A US$10.91 Price Target

Price target decreased to US$10.91

Forecast to breakeven in 2024

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Amyris, Inc. Provides Revenue Guidance for 2022

Amyris' Vertically-Integrated Business Model Transitioning From Investment Mode To Payoff Mode

Amyris, Inc. to Report Q2, 2022 Results on Aug 09, 2022

President recently sold US$118k worth of stock

Amyris: Revenues Need To Catch Expenses

Chief Legal Officer & Secretary notifies of intention to sell stock

Amyris, Inc. Announces Executive Changes Effective June 17, 2022

CFO & Chief Administration Officer recently sold US$82k worth of stock

High number of new directors

Amyris, Inc., Annual General Meeting, Jun 10, 2022

Amyris: Elevated Cash Usage Causes Investors To Head For The Exits

Amyris, Inc. to Report Q1, 2022 Results on May 10, 2022

Amryis Update: Building Value One Brick At A Time

Amyris, Inc. (NasdaqGS:AMRS) entered into an Agreement and Plan of Merger and Reorganization to acquire Onda Beauty Inc.

Desglose de ingresos y gastos

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado